Pediatric Diabetes最新文献

{"title":"ISPAD Clinical Practice Consensus Guidelines 2022: Psychological care of children, adolescents and young adults with diabetes.","authors":"Maartje de Wit, Katarzyna A Gajewska, Eveline R Goethals, Vincent McDarby, Xiaolei Zhao, Given Hapunda, Alan M Delamater, Linda A DiMeglio","doi":"10.1111/pedi.13428","DOIUrl":"https://doi.org/10.1111/pedi.13428","url":null,"abstract":"several","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1373-1389"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/66/PEDI-23-1373.PMC10107478.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Type 1 diabetes knowledge assessment: The KAT-1 validation study.","authors":"Anastasia Albanese-O'Neill,&nbsp;Jann MacInnes,&nbsp;Michael J Haller,&nbsp;Janey Adams,&nbsp;Nicole Thomas,&nbsp;Angelina Bernier","doi":"10.1111/pedi.13414","DOIUrl":"https://doi.org/10.1111/pedi.13414","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to examine the reliability and validity of a novel pediatric type 1 diabetes knowledge assessment (KAT-1) designed for children, adolescents, young adults and their parents/guardians. The instrument was designed to be integrated into the clinic workflow to obtain objective data electronically.</p><p><strong>Research design and methods: </strong>KAT-1 was developed by a multidisciplinary team and includes 11 independent topical subscales. Forty children/caregivers participated in a pilot study; their feedback was used to improve item clarity and readability. Subsequently, a validation study was performed in 200 participants (100 children/adolescents/young adults with type 1 diabetes ages 11-21 years and 100 parents/guardians of children with type 1 diabetes ages 1-15 years) to examine correlations between the KAT-1 scores and Revised Diabetes Knowledge Test (DKT2) scores and HbA1c. An item analysis was conducted to determine internal consistency and reliability; topical subscales were evaluated using Cronbach's alpha.</p><p><strong>Results: </strong>Total KAT-1 scores were positively correlated with DKT2 scores r = 0.674, p < 0.001, and negatively correlated with HbA1c, r = -0.3, p < 0.001. All KAT-1 subscales were positively and significantly correlated with one another and with total KAT-1 score. Internal consistency of total KAT-1 score was strong (Cronbach's α = 0.938, mean score 84.6, SD = 16.1) and 9 of 11 independent topical subscales demonstrated strong internal consistency. Completion time for subscales was <5 min.</p><p><strong>Conclusions: </strong>KAT-1 is a valid instrument to assess type 1 diabetes knowledge. The instrument's short topical subscales can be used to objectively assess specific knowledge and individualize diabetes education. KAT-1 has been integrated into our electronic health record (EPIC) and is available online at no cost.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1687-1694"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10440504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery.","authors":"Jennifer L Sherr,&nbsp;Melissa Schoelwer,&nbsp;Tiago Jeronimo Dos Santos,&nbsp;Leenatha Reddy,&nbsp;Torben Biester,&nbsp;Alfonso Galderisi,&nbsp;Jacobus Cornelius van Dyk,&nbsp;Marisa E Hilliard,&nbsp;Cari Berget,&nbsp;Linda A DiMeglio","doi":"10.1111/pedi.13421","DOIUrl":"https://doi.org/10.1111/pedi.13421","url":null,"abstract":"LGS is strongly recommended for all people with T1D to reduce the severity and duration of hypoglycemia. A","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1406-1431"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10441131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Issue Information","authors":"","doi":"10.1111/pedi.13228","DOIUrl":"https://doi.org/10.1111/pedi.13228","url":null,"abstract":"","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46905625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utility of plasma beta-hydroxybutyrate to define resolution of diabetic ketoacidosis.","authors":"Elise Schlissel Tremblay, Kate Millington, Yunhong Wu, David Wypij, Yufan Yang, Michael S D Agus, Joseph Wolfsdorf","doi":"10.1111/pedi.13437","DOIUrl":"10.1111/pedi.13437","url":null,"abstract":"<p><strong>Background: </strong>Diabetic ketoacidosis (DKA) is a common, life-threatening complication of type 1 diabetes (T1D) characterized by unregulated ketogenesis caused by relative or absolute insulin deficiency. DKA management requires frequent biochemical monitoring. Plasma ß-hydroxybutyrate (BOHB) has not been included in traditional definitions of DKA resolution.</p><p><strong>Objective: </strong>The aim of this study was to determine a cut-point level of BOHB to define DKA resolution in patients with T1D treated with intravenous (IV) insulin.</p><p><strong>Subjects: </strong>We identified patients with T1D receiving IV insulin for DKA treatment at a quaternary children's hospital from January 1, 2017 through December 31, 2020 who had plasma measurements of BOHB after DKA onset and whose DKA resolved by traditional laboratory criteria (venous pH (vpH) ≥ 7.3, serum bicarbonate (HCO₃ ) ≥ 15 mmol/L, and/or anion gap (AG) ≤ 14 mmol/L).</p><p><strong>Methods: </strong>Associations between plasma BOHB and vpH, HCO₃ , and AG were evaluated via scatterplots. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were used to evaluate BOHB cut-points to predict DKA resolution.</p><p><strong>Results: </strong>We analyzed 403 patients with 471 unique encounters. Plasma BOHB showed the most robust relationship with AG. The ROC curve comparing plasma BOHB to the accepted definition of DKA resolution, AG ≤14 mmol/L, had an AUC of 0.92. A BOHB value of <1.5 mmol/L had a sensitivity of 83% and specificity of 87%; this cut-point correctly classified 86% of the observations.</p><p><strong>Conclusions: </strong>A plasma BOHB value of <1.5 mmol/L can be used to define resolution of DKA.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1621-1627"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10446943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.","authors":"Rachel E J Besser,&nbsp;Kirstine J Bell,&nbsp;Jenny J Couper,&nbsp;Anette-G Ziegler,&nbsp;Diane K Wherrett,&nbsp;Mikael Knip,&nbsp;Cate Speake,&nbsp;Kristina Casteels,&nbsp;Kimberly A Driscoll,&nbsp;Laura Jacobsen,&nbsp;Maria E Craig,&nbsp;Michael J Haller","doi":"10.1111/pedi.13410","DOIUrl":"https://doi.org/10.1111/pedi.13410","url":null,"abstract":"The stages of type 1 diabetes (T1D) provide common ground for global efforts to prevent DKA and delay progression to disease in children and adolescents: An ISPAD consensus guideline. with normal glucose tolerance (via OGTT); Stage 2=multiple AAb-positive with abnormal glucose tolerance; Stage 3=clinical diagnosis of T1D","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1175-1187"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10499183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adolescent ambivalence about diabetes technology-The Janus faces of automated care.","authors":"Fergus J Cameron,&nbsp;Michael Arnold,&nbsp;John W Gregory","doi":"10.1111/pedi.13423","DOIUrl":"https://doi.org/10.1111/pedi.13423","url":null,"abstract":"<p><p>The Janus face metaphor approach highlights that a technology may simultaneously have two opposite faces or properties with unforeseen paradoxes within human-technology interaction. Suboptimal acceptance and clinical outcomes are sometimes seen in adolescents who use diabetes-related technologies. A traditional linear techno-determinist model of technology use would ascribe these unintended outcomes to suboptimal technology, suboptimal patient behavior, or suboptimal outcome measures. This paradigm has demonstratively not been successful at universally improving clinical outcomes over the last two decades. Alternatively, the Janus face metaphor moves away from a linear techno-determinist model and focuses on the dynamic interaction of the human condition and technology. Specifically, it can be used to understand variance in adoption or successful use of diabetes-related technology and to retrospectively understand suboptimal outcomes. The Janus face metaphor also allows for a prospective exploration of potential impacts of diabetes-related technology by patients, families, and their doctors so as to anticipate and minimize potential subsequent tensions.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1717-1724"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/3d/PEDI-23-1717.PMC10091736.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9296997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers.","authors":"Frida Sundberg,&nbsp;Carine deBeaufort,&nbsp;Lars Krogvold,&nbsp;Susana Patton,&nbsp;Thereza Piloya,&nbsp;Carmel Smart,&nbsp;Michelle Van Name,&nbsp;Jill Weissberg-Benchell,&nbsp;Jose Silva,&nbsp;Linda A diMeglio","doi":"10.1111/pedi.13427","DOIUrl":"https://doi.org/10.1111/pedi.13427","url":null,"abstract":"The Queen Silvia Childrens Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Pediatrics, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden Clinique Pédiatrique, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg Department of Pediatric Endocrinology, Universitair Ziekenhuis Brussel–Vrije Universiteit Brussel, Brussels, Belgium Paediatric Department, Oslo University Hospital, Oslo, Norway Center for Healthcare Delivery Science, Nemours Children's Health, Jacksonville, Florida, USA Department of Paediatrics & Child Health, School of Medicine, College of Health Sciences Makerere University, Kampala, Uganda Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital and School of Health Sciences, University of Newcastle, Newcastle, New South Wales, Australia Yale School of Medicine, New Haven, Connecticut, USA Department of Psychiatry and Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA SummitStone Health Partners, Fort Collins, Colorado, USA Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1496-1511"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4a/0c/PEDI-23-1496.PMC10108244.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9830506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross-sectional study of 156,090 children and adolescents with type 1 diabetes.","authors":"Natasa Bratina, Marie Auzanneau, Niels Birkebaek, Carine de Beaufort, Valentino Cherubini, Maria E Craig, Dana Dabelea, Klemen Dovc, Sabine E Hofer, Reinhard W Holl, Elizabeth T Jensen, Dick Mul, Katrin Nagl, Holly Robinson, Ulrike Schierloh, Jannet Svensson, Valentina Tiberi, Henk J Veeze, Justin T Warner, Kim C Donaghue","doi":"10.1111/pedi.13416","DOIUrl":"10.1111/pedi.13416","url":null,"abstract":"<p><strong>Objective: </strong>To examine the prevalence, time trends, and risk factors of diabetic retinopathy (DR) among youth with type 1 diabetes (T1D) from 11 countries (Australia, Austria, Denmark, England, Germany, Italy, Luxemburg, Netherlands, Slovenia, United States, and Wales).</p><p><strong>Subjects and methods: </strong>Data on individuals aged 10-21 years with T1D for >1 year during the period 2000-2020 were analyzed. We used a cross-sectional design using the most recent year of visit to investigate the time trend. For datasets with longitudinal data, we aggregated the variables per participant and observational year, using data of the most recent year to take the longest observation period into account. DR screening was performed through quality assured national screening programs. Multiple logistic regression models adjusted for the year of the eye examination, age, gender, minority status, and duration of T1D were used to evaluate clinical characteristics and the risk of DR.</p><p><strong>Results: </strong>Data from 156,090 individuals (47.1% female, median age 15.7 years, median duration of diabetes 5.2 years) were included. Overall, the unadjusted prevalence of any DR was 5.8%, varying from 0.0% (0/276) to 16.2% between countries. The probability of DR increased with longer disease duration (aOR_{per-1-year-increase}  = 1.04, 95% CI: 1.03-1.04, p < 0.0001), and decreased over time (aOR_{per-1-year-increase}  = 0.99, 95% CI: 0.98-1.00, p = 0.0093). Evaluating possible modifiable risk factors in the exploratory analysis, the probability of DR increased with higher HbA1c (aOR_{per-1-mmol/mol-increase-in-HbA1c}  = 1.03, 95% CI: 1.03-1.03, p < 0.0001) and was higher among individuals with hypertension (aOR = 1.24, 95% CI: 1.11-1.38, p < 0.0001) and smokers (aOR = 1.30, 95% CI: 1.17-1.44, p < 0.0001).</p><p><strong>Conclusions: </strong>The prevalence of DR in this large cohort of youth with T1D varied among countries, increased with diabetes duration, decreased over time, and was associated with higher HbA1c, hypertension, and smoking.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1656-1664"},"PeriodicalIF":3.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/3b/PEDI-23-1656.PMC9771999.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10293796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Survival of children and youth with type 1 diabetes mellitus in Tanzania.","authors":"Edna Siima Majaliwa,&nbsp;Linda Minja,&nbsp;Joel Ndayongeje,&nbsp;Kaushik Ramaiya,&nbsp;Sayoki G Mfinanga,&nbsp;Blandina T Mmbaga","doi":"10.1111/pedi.13425","DOIUrl":"https://doi.org/10.1111/pedi.13425","url":null,"abstract":"<p><strong>Introduction: </strong>Survival from type 1 diabetes Mellitus is low in lower-income countries with underdeveloped health systems. Support programs from partners like life for a child (LFAC) and changing diabetes in children (CDiC) were implemented in Tanzania in 2005 to provide diabetes care to children and youth. No evaluation of survival has been done since their implementation.</p><p><strong>Objective: </strong>To assess the survival of children and youth living with diabetes mellitus (CYLDM) in Tanzania.</p><p><strong>Methods: </strong>A retrospective data collection from 39 clinics of CYLDM was done by extracting data from the diabetes registry between 1991 and 2019. Three cohort were analyzed (1) Cohort 1991-2004 (pre-implementation), (2) Cohort 2005-2010 (during implementation), and (3) 2011-2019 (after the implementation of LFAC/CDiC). Data were analyzed using STATA-version 14.</p><p><strong>Results: </strong>A total of 3822 data of CYLDM were extracted, mean age at diagnosis was 13.8 (±5) years. Approximately fifty-one percent (50.8%) were male. The total observation time was 28 years, and the Median duration of diabetes of 5 (IQR2, 8) years. Total death was 95 (3%), with a mean age at death of 17.7 (SD 4.7) years. The last cohort (2011-2019) had more diagnosis 2353 (72.7%), as compared to the <2005 cohort with only 163(5%). The survival improved from 59% before 2005 to 69% in the last cohort (2011-2019).</p><p><strong>Conclusion: </strong>The implemented programs have facilitated the diagnosis and retention of CYLDM in the health care system. In doing so, it has also increased the survival probability in Tanzania compared to the early 90s.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"23 8","pages":"1560-1566"},"PeriodicalIF":3.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10431884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}